Multiple Sclerosis International / 2014 / Article / Tab 5

Research Article

Multiple Sclerosis State of the Art (SMART): A Qualitative and Quantitative Analysis of Therapy’s Adherence, Hospital Reliability’s Perception, and Services Provided Quality

Table 5

Main factors in the choice of MS Therapy.

Three monthsTwelve months

The drug’s mechanism of action
The drug reduces the relapses
The drug slows the disease progression
The drug produces fewer antibodies
The drug is well known
The drug has few side effects
The drug improves the MRI
The nurse support for injections
Information support of the company producing the drug
The intramuscular or subcutaneous mode of administration
The ability to let by myself injections
The availability of an autoinjector
How many times a week should I take the drug?
The independence that a treatment can give